Agilent Technologies describes a CAR T-cell killing assay that combines the sensitivity and objectivity of real-time impedance monitoring with the highly specific readouts of live-cell imaging.

Your Must-Attend Meeting to Advance Your Potency Assay StrategyThe inaugural Cell Therapy Potency Assay Summit is the first and only industry defining forum set to address the complexity of measuring ...

The CardiAMP cell potency assay is an important element of the CardiAMP Cell Therapy System development and is believed to be the first assay of its kind proposed as a quality-based inclusion ...

In vitro potency assays for small molecules and biologics are simpler than those for cell and gene therapies (CGTs). To deal with CGT complexities, says Absorption Systems, try a step-by-step ...

Join the 4th Cell Therapy Potency Assay Summit hosted by Hanson Wade to discover the latest advancements in cell therapy potency assays and network with industry leaders.

Slingshot Biosciences, the leader in precision-engineered cell mimic technologies, today announced the launch of TruCytes™ Potency, a new class of biomarker cell mimics specifically designed for ...

Download this application note to discover an assay solution for studying and optimizing CAR T cells that can monitor key cell attributes continuously, capture live cell images and track the continuum ...

The 3rd Cell Therapy Potency Assay Summit will bring together 100+ analytical, QC and regulatory experts to discuss the new FDA guidance and address all pressing concerns that are limiting ...

EMERYVILLE, Calif., May 06, 2025--Slingshot Biosciences, the leader in precision-engineered cell mimic technologies, today announced the launch of TruCytes™ Potency, a new class of biomarker ...

Potency assay will leverage the product's mechanism of action to define the biological activity. The absence of rigorous mechanistic data for the majority of cell and gene therapy therapeutics ...